glp 1 agonist or antagonist GLP-1 Agonists - What is it? The Premise of the Paradox:
Description
90 mg: -2.50, p=0.0008)

As a result, you feel full for a more extended period after eating, reducing the urge to consume additional calories

Retatrutide: A Triple Agonist with Unprecedented Efficacy Retatrutide (LY3437943) is a novel triple incretin agonist that simultaneously targets the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors

They named it 'glucagon' (GLUCose-AGONist) on account that it seemed to be a 'glucose driving hormone' (Unger

Common side effects are injection site reactions, nausea, abdominal discomfort, flu-like symptoms, and skin hyperpigmentation [48]
